{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:15:35Z","timestamp":1788218135346,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":94,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Antimicrob Resist"],"DOI":"10.1038\/s44259-026-00201-y","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T17:46:07Z","timestamp":1780163167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploiting DprE2 pathway redundancy to enhance potency and overcome resistance to pretomanid in Mycobacterium tuberculosis"],"prefix":"10.1038","volume":"4","author":[{"given":"Kamel","family":"Djaout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Dreneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9o","family":"Faion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Prieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Neuville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Boulloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Biela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosangela","family":"Frita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Devaere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Slupek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudy","family":"Antoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben C.","family":"Hartkoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Vandeputte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Piveteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Leroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Dumont-Ryckembusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Herledan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"P\u00e1l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Z\u00e1horszk\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katar\u00edna","family":"Miku\u0161ov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Kordul\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Guilhot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"D\u00e9prez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Flipo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Baulard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Willand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"key":"201_CR1","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/35016103","volume":"405","author":"CK Stover","year":"2000","unstructured":"Stover, C. K. et al. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature 405, 962\u2013966 (2000).","journal-title":"Nature"},{"key":"201_CR2","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1126\/science.1164571","volume":"322","author":"R Singh","year":"2008","unstructured":"Singh, R., Manjunatha, U., Boshoff, H. I. & Ha, Y. H. PN. PA-824 kills nonreplicating. Science 322, 1392\u20131395 (2008).","journal-title":"Science"},{"key":"201_CR3","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1371\/journal.pmed.0030466","volume":"3","author":"M Matsumoto","year":"2006","unstructured":"Matsumoto, M. et al. OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice. PLoS Med. 3, 2131\u20132144 (2006).","journal-title":"PLoS Med."},{"key":"201_CR4","first-page":"1","volume":"61","author":"M Matsuba","year":"2017","unstructured":"Matsuba, M. et al. Delamanid kills dormant mycobacteria in vitro and in a Guinea Pig model of tuberculosis. Antimicrob. Agents Chemother. 61, 1\u201311 (2017).","journal-title":"Antimicrob. Agents Chemother."},{"key":"201_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-29832-1","volume":"13","author":"KM Kreutzfeldt","year":"2022","unstructured":"Kreutzfeldt, K. M. et al. CinA mediates multidrug tolerance in Mycobacterium tuberculosis. Nat. Commun. 13, 1\u201312 (2022).","journal-title":"Nat. Commun."},{"key":"201_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.01755-19","volume":"64","author":"M Hayashi","year":"2020","unstructured":"Hayashi, M. et al. Adduct formation of delamanid with NAD in mycobacteria. Antimicrob. Agents Chemother. 64, 1\u201312 (2020).","journal-title":"Antimicrob. Agents Chemother."},{"key":"201_CR7","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1038\/s41467-023-39300-z","volume":"14","author":"KA Abrahams","year":"2023","unstructured":"Abrahams, K. A. et al. DprE2 is a molecular target of the anti-tubercular nitroimidazole compounds pretomanid and delamanid. Nat. Commun. 14, 3828 (2023).","journal-title":"Nat. Commun."},{"key":"201_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.4161\/cib.2.3.7926","volume":"2","author":"U Manjunatha","year":"2009","unstructured":"Manjunatha, U., Boshoff, H. I. M. & Barry, C. E. The mechanism of action of PA-824: novel insights from transcriptional profiling. Commun. Integr. Biol. 2, 215\u2013218 (2009).","journal-title":"Commun. Integr. Biol."},{"key":"201_CR9","doi-asserted-by":"crossref","unstructured":"Rifat, D. et al. Mutations in fbiD (Rv2983) as a novel determinant of resistance to pretomanid and delamanid in mycobacterium tuberculosis. Antimicrob. Agents Chemother. 65 (2021).","DOI":"10.1128\/AAC.01948-20"},{"key":"201_CR10","doi-asserted-by":"publisher","first-page":"5316","DOI":"10.1128\/AAC.00308-15","volume":"59","author":"HL Haver","year":"2015","unstructured":"Haver, H. L. et al. Mutations in genes for the F420 biosynthetic pathway and a nitroreductase enzyme are the primary resistance determinants in spontaneous in vitro-selected PA-824-resistant mutants of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 59, 5316\u20135323 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"201_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1073\/pnas.0508392103","volume":"103","author":"UH Manjunatha","year":"2006","unstructured":"Manjunatha, U. H. et al. Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 103, 431\u2013436 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"201_CR12","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.tube.2017.12.006","volume":"108","author":"M Fujiwara","year":"2018","unstructured":"Fujiwara, M., Kawasaki, M., Hariguchi, N., Liu, Y. & Matsumoto, M. Mechanisms of resistance to delamanid, a drug for Mycobacterium tuberculosis. Tuberculosis 108, 186\u2013194 (2018).","journal-title":"Tuberculosis"},{"key":"201_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-98862-4","volume":"11","author":"PJ G\u00f3mez-Gonz\u00e1lez","year":"2021","unstructured":"G\u00f3mez-Gonz\u00e1lez, P. J. et al. Genetic diversity of candidate loci linked to Mycobacterium tuberculosis resistance to bedaquiline, delamanid and pretomanid. Sci. Rep. 11, 1\u201313 (2021).","journal-title":"Sci. Rep."},{"key":"201_CR14","doi-asserted-by":"publisher","unstructured":"Brendon, M. et al. The evolution of nitroimidazole antibiotic resistance in Mycobacterium tuberculosis. bioRxiv 631127. https:\/\/doi.org\/10.1101\/631127 (2019).","DOI":"10.1101\/631127"},{"key":"201_CR15","doi-asserted-by":"publisher","first-page":"668","DOI":"10.7164\/antibiotics.29.668","volume":"29","author":"GN Rolinson","year":"1976","unstructured":"Rolinson, G. N. Naturally-occurring \u03b2-lactamase inhibitors with antibacterial activity. J. Antibiot. 29, 668\u2013669 (1976).","journal-title":"J. Antibiot."},{"key":"201_CR16","doi-asserted-by":"publisher","first-page":"10510","DOI":"10.1073\/pnas.1818009116","volume":"116","author":"K Flentie","year":"2019","unstructured":"Flentie, K. et al. Chemical disarming of isoniazid resistance in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 116, 10510\u201310517 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"201_CR17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nm.1950","volume":"15","author":"N Willand","year":"2009","unstructured":"Willand, N. et al. Synthetic EthR inhibitors boost antituberculous activity of ethionamide. Nat. Med. 15, 537\u2013544 (2009).","journal-title":"Nat. Med."},{"key":"201_CR18","doi-asserted-by":"crossref","unstructured":"Blondiaux, N. et al. Reversion of antibiotic resistance in Mycobacterium tuberculosis by spiroisoxazoline SMARt-420. Science 355, 1206\u20131211 (2017).","DOI":"10.1126\/science.aag1006"},{"key":"201_CR19","doi-asserted-by":"publisher","unstructured":"Flipo, M. et al. Small-molecule SMARt751 hypersensitizes M. tuberculosis resistant to ethionamide by upregulating the mymA operon. Sci. Transl. Med. 14, https:\/\/doi.org\/10.1126\/SCITRANSLMED.AAZ6280 (2022).","DOI":"10.1126\/SCITRANSLMED.AAZ6280"},{"key":"201_CR20","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1056\/NEJMc2504287","volume":"394","author":"M Pieren","year":"2026","unstructured":"Pieren, M. et al. Revival of Ethionamide by Alpibectir. N. Engl. J. Med. 394, 818\u2013819 (2026).","journal-title":"N. Engl. J. Med."},{"key":"201_CR21","doi-asserted-by":"publisher","first-page":"E9549","DOI":"10.1073\/pnas.1706849114","volume":"114","author":"E Akiva","year":"2017","unstructured":"Akiva, E., Copp, J. N., Tokuriki, N. & Babbitt, P. C. Evolutionary and molecular foundations of multiple contemporary functions of the nitroreductase superfamily. Proc. Natl. Acad. Sci. USA 114, E9549\u2013E9558 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"201_CR22","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1476-5381.2010.01040.x","volume":"162","author":"M Dogra","year":"2011","unstructured":"Dogra, M. et al. Comparative bioactivation of the novel anti-tuberculosis agent PA-824 in Mycobacteria and a subcellular fraction of human liver. Br. J. Pharm. 162, 226\u2013236 (2011).","journal-title":"Br. J. Pharm."},{"key":"201_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nmeth996","volume":"4","author":"JC van Kessel","year":"2007","unstructured":"van Kessel, J. C., Hatfull, G. F., Kessel, J. C., Van & Hatfull, G. F. Recombineering in Mycobacterium tuberculosis. Nat. Methods 4, 147\u2013152 (2007).","journal-title":"Nat. Methods"},{"key":"201_CR24","doi-asserted-by":"crossref","unstructured":"Yan, M. Y. et al. CRISPR screening and comparative LC-MS analysis identify genes mediating efficacy of delamanid and pretomanid against Mycobacterium tuberculosis. Adv. Sci. 11 (2024).","DOI":"10.1002\/advs.202400176"},{"key":"201_CR25","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1099\/mic.0.2008\/016378-0","volume":"154","author":"X Meniche","year":"2008","unstructured":"Meniche, X. et al. Partial redundancy in the synthesis of the D-arabinose incorporated in the cell wall arabinan of Corynebacterineae. Microbiology 154, 2315\u20132326 (2008).","journal-title":"Microbiology"},{"key":"201_CR26","doi-asserted-by":"publisher","first-page":"14526","DOI":"10.1021\/acs.jmedchem.1c01049","volume":"64","author":"D Fan","year":"2021","unstructured":"Fan, D. et al. Structural and activity relationships of 6-sulfonyl-8-nitrobenzothiazinones as antitubercular agents. J. Med. Chem. 64, 14526\u201314539 (2021).","journal-title":"J. Med. Chem."},{"key":"201_CR27","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1073\/pnas.052548299","volume":"99","author":"R Brosch","year":"2002","unstructured":"Brosch, R. et al. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc. Natl. Acad. Sci. USA 99, 3684\u20133689 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"201_CR28","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1093\/jac\/dkac070","volume":"77","author":"A Bateson","year":"2022","unstructured":"Bateson, A. et al. Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid. J. Antimicrob. Chemother. 77, 1685\u20131693 (2022).","journal-title":"J. Antimicrob. Chemother."},{"key":"201_CR29","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/bioinformatics\/btr026","volume":"27","author":"R Schmieder","year":"2011","unstructured":"Schmieder, R. & Edwards, R. Quality control and preprocessing of metagenomic datasets. Bioinformatics 27, 863\u2013864 (2011).","journal-title":"Bioinformatics"},{"key":"201_CR30","unstructured":"Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. http:\/\/arxiv.org\/abs\/1303.3997 (2013)."},{"key":"201_CR31","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna, A. et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297\u20131303 (2010).","journal-title":"Genome Res."},{"key":"201_CR32","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani, P. et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly 6, 80\u201392 (2012).","journal-title":"Fly"},{"key":"201_CR33","doi-asserted-by":"crossref","unstructured":"Payros, D. et al. Rv0180c contributes to Mycobacterium tuberculosis cell shape and to infectivity in mice and macrophages. PLoS Pathog. 17 (2021).","DOI":"10.1371\/journal.ppat.1010020"},{"key":"201_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1046\/j.1365-2958.2003.03425.x","volume":"48","author":"CM Sassetti","year":"2003","unstructured":"Sassetti, C. M., Boyd, D. H. & Rubin, E. J. Genes required for mycobacterial growth defined by high density mutagenesis. Mol. Microbiol. 48, 77\u201384 (2003).","journal-title":"Mol. Microbiol."},{"key":"201_CR35","doi-asserted-by":"crossref","unstructured":"DeJesus, M. A. et al. Statistical analysis of genetic interactions in Tn-Seq data. Nucleic Acids Res. 45, e93 (2017).","DOI":"10.1093\/nar\/gkx128"}],"container-title":["npj Antimicrobials and Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44259-026-00201-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44259-026-00201-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44259-026-00201-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T22:37:41Z","timestamp":1788215861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44259-026-00201-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["201"],"URL":"https:\/\/doi.org\/10.1038\/s44259-026-00201-y","relation":{},"ISSN":["2731-8745"],"issn-type":[{"value":"2731-8745","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N.W., A.D., L.F., M.F., M.P. (Univ. Lille, Inserm, Institut Pasteur de Lille), A.R.B. and K.D. (Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille) are inventors on patent Application PCT\/EP2023\/050182 covering the boosters of pretomanid described in this manuscript. The remaining authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"52"}}